KENNETH DABOLT: Open Payments
NPI 1881189116 · SPRINGVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 57 payments from 18 companies in 2025. Trend: 2023 $2,087 · 2024 $1,729 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $329 |
| Lilly USA, LLC | 11 | $260 |
| Novo Nordisk Inc | 5 | $110 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Axsome Therapeutics, Inc. | 1 | $88 |
| Amgen Inc. | 5 | $82 |
| ABBVIE INC. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Edwards Lifesciences Corporation | 3 | $59 |
Products named: AIRSUPRA, BREZTRI, ZEPBOUND, Auvelity, MOUNJARO, SHINGRIX, VOQUEZNA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
